Come up with a name for your new list and we'll add to it:
Neurotec Pharma raised a round of funding on December 20, 2012. Investors include
Caixa Capital Risc.
Neurotec Pharma centres its activity around the development of new products used for therapy in the field of acute and chronic diseases of the central nervous system, with particular interest on multi…